Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer

Nature Medicine

Volumn 25, Issue 4, 2019, Pages 679-689

  Wirbel, Jakob ^a   Pyl, Paul Theodor ^b,c   Kartal, Ece ^a,d   Zych, Konrad ^a   Kashani, Alireza ^b   Milanese, Alessio ^a   Fleck, Jonas S ^a   Voigt, Anita Y ^a,e   Palleja, Albert ^b   Ponnudurai, Ruby ^a   Sunagawa, Shinichi ^a,f   Coelho, Luis Pedro ^a,z   Schrotz King, Petra ^g   Vogtmann, Emily ^h   Habermann, Nina ^a   Niméus, Emma ^c,i   Thomas, Andrew M ^j,k   Manghi, Paolo ^j   Gandini, Sara ^l   Serrano, Davide ^l   Mizutani, Sayaka ^m,n   Shiroma, Hirotsugu ^m   Shiba, Satoshi ^o   Shibata, Tatsuhiro ^o,p   Yachida, Shinichi ^o,q   Yamada, Takuji ^m,r   Waldron, Levi ^s   Naccarati, Alessio ^t,u   Segata, Nicola ^j   Sinha, Rashmi ^h   Ulrich, Cornelia M ^v   Brenner, Hermann ^g   Arumugam, Manimozhiyan ^b,w   Bork, Peer ^a,d,x,y   Zeller, Georg ^a   more..

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b Capital Region   (Denmark)

^c LUND UNIVERSITY   (Sweden)

^d Molecular Medicine Partnership Unit (MMPU)   (Germany)

^e JACKSON LABORATORY   (United States)

^f ETH ZURICH   (Switzerland)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j UNIVERSITY OF TRENTO   (Italy)

^k UNIVERSITY OF SÃO PAULO   (Brazil)

^l EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^m TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

ⁿ JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^o NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^p UNIVERSITY OF TOKYO   (Japan)

^q OSAKA UNIVERSITY   (Japan)

^r JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^s CITY UNIVERSITY OF NEW YORK   (United States)

^t IIGM Italian Institute for Genomic Medicine   (Italy)

^u INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^v UNIVERSITY OF UTAH   (United States)

^w UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^x MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^y UNIVERSITY OF WÜRZBURG   (Germany)

^z FUDAN UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CARBOHYDRATE; MUCIN; TUMOR MARKER;

ARTICLE; CATABOLISM; COLORECTAL CANCER; HUMAN; INTESTINE; METAGENOME; METAGENOMICS; PRIORITY JOURNAL; ADENOMA; AGED; BIOLOGICAL MODEL; COHORT ANALYSIS; COLORECTAL TUMOR; FECES; FEMALE; GENETIC DATABASE; GENETICS; INTESTINE FLORA; MALE; META ANALYSIS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; REPRODUCIBILITY; SPECIES DIFFERENCE;

ADENOMA; AGED; BIOMARKERS, TUMOR; COHORT STUDIES; COLORECTAL NEOPLASMS; DATABASES, GENETIC; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; METAGENOME; MIDDLE AGED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SPECIES SPECIFICITY;

EID: 85063786613     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/s41591-019-0406-6     Document Type: Article

References (80)

1. Tringe, S. G. & Rubin, E. M. Metagenomics: DNA sequencing of environmental samples. Nat. Rev. Genet. 6, 805–814 (2005).
2. Tremaroli, V. & Bäckhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242–249 (2012).
3. Lynch, S. V. & Pedersen, O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 375, 2369–2379 (2016).
4. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012).
5. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103 (2013).
6. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
7. Schirmer, M. et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat. Microbiol. 3, 337–346 (2018).
8. Zeller, G. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 10, 766 (2014).
9. Feng, Q. et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat. Commun. 6, 6528 (2015).
10. Vogtmann, E. et al. Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing. PLoS ONE 11, e0155362 (2016).
11. Yu, J. et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66, 70–78 (2017).
12. Bedarf, J. R. et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients. Genome Med. 9, 39 (2017).
13. Schmidt, T. S. B., Raes, J. & Bork, P. The human gut microbiome: from association to modulation. Cell 172, 1198–1215 (2018).
14. Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015).
15. Costea, P. I. et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069–1076 (2017).
16. Lozupone, C. A. et al. Meta-analyses of studies of the human microbiota. Genome Res. 23, 1704–1714 (2013).
17. Duvallet, C., Gibbons, S. M., Gurry, T., Irizarry, R. A. & Alm, E. J. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat. Commun. 8, 1784 (2017).
18. Shah, M. S. et al. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer. Gut 67, 882–891 (2018).
19. Pasolli, E., Truong, D. T., Malik, F., Waldron, L. & Segata, N. Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput. Biol. 12, e1004977 (2016).
20. Dai, Z. et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome 6, 70 (2018).
21. Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).
22. Milanese, M. et al. Microbial abundance, activity and population genomic profiling with mOTUs2. Nat. Commun. 10, 1014 (2019).
23. Kultima, J. R. et al. MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics 32, 2520–2523 (2016).
24. Hothorn, T. et al. A Lego system for conditional inference. Am. Stat. 60, 257–263 (2006).
25. Mandal, S. et al. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb. Ecol. Health Dis. 26, 27663 (2015).
26. Tjalsma, H., Boleij, A., Marchesi, J. R. & Dutilh, B. E. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 10, 575–582 (2012).
27. Thomas, A. M. et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat. Med. 10.1038/s41591-019-0405-7 (2019).
28. Huerta-Cepas, J. et al.eggNOG 4.5: a hierarchical orthology framework with improved functional annotations for eukaryotic, prokaryotic and viral sequences. Nucleic Acids Res. 44, D286–D293 (2016).
29. Kanehisa, M. et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 42, D199–D205 (2014).
30. Li, J. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834–841 (2014).
31. Vieira-Silva, S. et al. Species–function relationships shape ecological properties of the human gut microbiome. Nat. Microbiol. 1, 16088 (2016).
32. Hirayama, A. et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918–4925 (2009).
33. Denkert, C. et al. Metabolite profiling of human colon carcinoma: deregulation of TCA cycle and amino acid turnover. Mol. Cancer 7, 72 (2008).
34. Mal, M., Koh, P. K., Cheah, P. Y. & Chan, E. C. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry. Anal. Bioanal. Chem. 403, 483–493 (2012).
35. Weir, T. L. et al. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS ONE 8, e70803 (2013).
36. Goedert, J. J. et al. Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis 35, 2089–2096 (2014).
37. Aykan, N. F. Red meat and colorectal cancer. Oncol. Rev. 9, 288 (2015).
38. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. A Summary of the Third Expert Report (World Cancer Research Fund, 2018).
39. Dutilh, B. E., Backus, L., van Hijum, S. A. & Tjalsma, H. Screening metatranscriptomes for toxin genes as functional drivers of human colorectal cancer. Best Pract. Res. Clin. Gastroenterol. 27, 85–99 (2013).
40. Sears, C. L. & Garrett, W. S. Microbes, microbiota, and colon cancer. Cell Host Microbe 15, 317–328 (2014).
41. Ridlon, J. M., Harris, S. C., Bhowmik, S., Kang, D. J. & Hylemon, P. B. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7, 22–39 (2016).
42. Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97–101 (2013).
43. Ajouz, H., Mukherji, D. & Shamseddine, A. Secondary bile acids: an underrecognized cause of colon cancer. World J. Surg. Oncol. 12, 164 (2014).
44. Boleij, A. et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60, 208–215 (2015).
45. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016–1022 (2009).
46. Dejea, C. M. et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359, 592–597 (2018).
47. Ridlon, J. M., Kang, D. J. & Hylemon, P. B. Isolation and characterization of a bile acid inducible 7α-dehydroxylating operon in Clostridium hylemonae TN271. Anaerobe 16, 137–146 (2010).
48. Mallonee, D. H., White, W. B. & Hylemon, P. B. Cloning and sequencing of a bile acid-inducible operon from Eubacterium sp. strain VPI 12708. J. Bacteriol. 172, 7011–7019 (1990).
49. Ocvirk, S. & O’Keefe, S. J. D. Influence of bile acids on colorectal cancer risk: potential mechanisms mediated by diet–gut microbiota interactions. Curr. Nutr. Rep. 6, 315–322 (2017).
50. Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15, 382–392 (2014).
51. Viennot, S. et al. Colon cancer in inflammatory bowel disease: recent trends, questions and answers. Gastroenterol. Clin. Biol. 33, S190–S201 (2009).
52. Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195–206 (2013).
53. Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207–215 (2013).
54. Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120–123 (2012).
55. Reddy, B. S. Diet and excretion of bile acids. Cancer Res. 41, 3766–3768 (1981).
56. Ogino, S. et al. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut 67, 1168–1180 (2018).
57. Ogino, S., Chan, A. T., Fuchs, C. S. & Giovannucci, E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 60, 397–411 (2011).
58. Hannigan, G. D., Duhaime, M. B., Ruffin, M. T. 4th, Koumpouras, C. C. & Schloss, P. D. Diagnostic potential and interactive dynamics of the colorectal cancer virome. MBio 9, e02248-18 (2018).
59. zur Hausen, H. Red meat consumption and cancer: reasons to suspect involvement of bovine infectious factors in colorectal cancer. Int. J. Cancer 130, 2475–2483 (2012).
60. Shkoporov, A. N. et al. Reproducible protocols for metagenomic analysis of human faecal phageomes. Microbiome 6, 68 (2018).
61. Böhm, J. et al. Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study. Surgery 161, 808–817 (2017).
62. Liesenfeld, D. B. et al. Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study. Am. J. Clin. Nutr. 102, 433–443 (2015).
63. Pox, C. P. et al. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 142, 1460–1467.e2 (2012).
64. Furet, J. P. et al. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol. Ecol. 68, 351–362 (2009).
65. Mende, D. R. et al. Accurate and universal delineation of prokaryotic species. Nat. Methods 10, 881–884 (2013).
66. Sunagawa, S. et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat. Methods 10, 1196–1199 (2013).
67. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
68. Tibshirani, R. Regression shrinkage and selection via the LASSO. J. R. Stat. Soc. B 58, 267–288 (1996).
69. Smialowski, P., Frishman, D. & Kramer, S. Pitfalls of supervised feature selection. Bioinformatics 26, 440–443 (2010).
70. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).
71. Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12, 77 (2011).
72. Oksanen, J. et al. vegan: Community Ecology Package (The Comprehensive R Archive Network, 2018).
73. Costea, P. I., Zeller, G., Sunagawa, S. & Bork, P. A fair comparison. Nat. Methods 11, 359 (2014).
74. Hastie, T., Tibshirani, R. & Friedman, J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction (Springer, 2009).
75. Peng, H., Long, F. & Ding, C. Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans. Pattern Anal. Mach. Intell. 27, 1226–1238 (2005).
76. Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797 (2004).
77. Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389–3402 (1997).
78. Eddy, S. R. Accelerated profile HMM searches. PLoS Comput. Biol. 7, e1002195 (2011).
79. Rice, P., Longden, I. & Bleasby, A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16, 276–277 (2000).
80. Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl Acad. Sci. USA 108, 4516–4522 (2011).